Image credit: Deccan Herald

According to official statistics, nearly 3.45 crore first doses have been administered to children aged 15 to 18.

Dr N K Arora, chairman of the COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI), said on Monday that India may begin inoculating youngsters in the 12–14 age group against COVID-19 in March because the 15–18 population is likely to be fully vaccinated by then.

Over 3.45 crore (7.40,577,000) of the expected 7.4 crores (7.40,577,000) people in the 15–18 age bracket have got their first dosage of Covaxin, with their second dose due in 28 days, he said. He predicted that once the 15–18 age range is covered, the government will make a policy decision in March about starting the vaccination campaign for the 12–14 age group.

According to him, the 12–14 age bracket has a population of 7.5 crore people.

Vaccination reports up until 7 a.m. Monday showed that more than 39 lakh doses were administered in less than 24 hours, bringing the total to 157.20 crore doses.

The nationwide immunisation campaign began on January 16 of last year, with healthcare workers (HCWs) being the first to be vaccinated. On February 2, 2021, frontline workers (FLWs) began receiving vaccinations.

The next round of the COVID-19 immunisation began on March 1st of last year for those over 60 years old and those aged 45 and over who have certain co-morbid disorders.

As of April 1, 2021, the country began a vaccination campaign for all adults over the age of 45. From May 1, the government decided to broaden its vaccination campaign by enabling anyone over the age of 18 to be vaccinated.

The next phase of COVID-19 immunisation for teenagers aged 15 to 18 years old began on January 3 of this year.

In response to a spike in coronavirus infections primarily caused by the virus’s Omicron variant, India began administering the “precaution dose,” a third dose of the COVID-19 vaccine to healthcare workers, including those deployed for election duty and those aged 60 and above with co-morbidities, on January 10.

LEAVE A REPLY

Please enter your comment!
Please enter your name here